Fidelity Investments’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Sell |
|
|||||
|
2025
Q1 | $15.3M | Buy |
|
|||||
|
2024
Q4 | $18.1M | Sell |
|
|||||
|
2024
Q3 | $21.6M | Buy |
|
|||||
|
2024
Q2 | $16.4M | Buy |
|
|||||
|
2024
Q1 | $17.5M | Buy |
|
|||||
|
2023
Q4 | $27.1M | Buy |
|
|||||
|
2023
Q3 | $45.8M | Buy |
|
|||||
|
2023
Q2 | $91.9M | Buy |
|
|||||
|
2023
Q1 | $107M | Buy |
|
|||||
|
2022
Q4 | $105M | Buy |
|
|||||
|
2022
Q3 | $119M | Buy |
|
|||||
|
2022
Q2 | $63.8M | Buy |
|
|||||
|
2022
Q1 | $98.8M | Buy |
|
|||||
|
2021
Q4 | $115M | Buy |
|
|||||
|
2021
Q3 | $95.8M | Buy |
|
|||||
|
2021
Q2 | $308M | Buy |
|
|||||
|
2021
Q1 | $253M | Buy |
|
|||||
|
2020
Q4 | $278M | Buy |
|
|||||
|
2020
Q3 | $303M | Buy |
|
|||||
|
2020
Q2 | $27.3M | Sell |
|
|||||
|
2020
Q1 | $22M | Sell |
|
|||||
|
2019
Q4 | $22.4M | Sell |
|
|||||
|
2019
Q3 | $28.7M | Sell |
|
|||||
|
2019
Q2 | $26.1M | Buy |
|
|||||
|
2019
Q1 | $40M | Sell |
|
|||||
|
2018
Q4 | $27.7M | Buy |
|
|||||
|
2018
Q3 | $46.4M | Buy |
|
|||||
|
2018
Q2 | $52.4M | Buy |
|
|||||
|
2018
Q1 | $44.7M | Buy |
|
|||||
|
2017
Q4 | $61.6M | Buy |
|
|||||
|
2017
Q3 | $97.4M | Buy |
|
|||||
|
2017
Q2 | $68.4M | Buy |
|
|||||
|
2017
Q1 | $68.2M | Buy |
|
|||||
|
2016
Q4 | $59.9M | Buy |
|
|||||
|
2016
Q3 | $74.2M | Buy |
|
|||||
|
2016
Q2 | $172M | Buy |
|
|||||
|
2016
Q1 | $156M | Buy |
|
|||||
|
2015
Q4 | $206M | Buy |
|
|||||
|
2015
Q3 | $173M | Buy |
|
|||||
|
2015
Q2 | $217M | Buy |
|